Stephen Howell

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

Anthony G Marson, Asya M Al-Kharusi, Muna Alwaidh et al. · The Lancet · 2007 · 969 citations · Full text

Partial Epilepsy, Psychotropic Medication, Pharmacotherapy +3

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

Anthony G Marson, Asya M Al-Kharusi, Muna Alwaidh et al. · The Lancet · 2007 · 959 citations · Full text

Unclassifiable Epilepsy, Psychiatry, Psychotropic Medication +5

Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy

Tanja Brenner, Graeme J. Sills, Yvonne Hart et al. · Epilepsia · 2013 · 228 citations · Full text

Autosomal Dominant Nocturnal Frontal-Lobe Epilepsy: Genetic Heterogeneity and Evidence for a Second Locus at 15q24

Hilary A. Phillips, Ingrid E. Scheffer, Kathryn M. Crossland et al. · The American Journal of Human Genetics · 1998 · 217 citations · Full text

Brain Structure, Genetic Disorder, Genetics +9

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 202 citations · Full text